News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valor Medical Finalizes EU Cerebral Aneurysm Clinical Trial



4/22/2010 10:42:54 AM

SAN DIEGO, April 22 /PRNewswire/ -- Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies. Basically, the aneurysms in the trial patients were uncommonly difficult and could not be treated with coil therapy, but Neucrylate AN demonstrated that even the most difficult aneurysms could be treated in a time efficient manner.

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES